基因组稳定的结直肠癌的临床病理和分子特征
Lingyan Jin1,2, Hye-Yeong Jin1,2, Younghoon Kim2,3
1Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
Histology and histopathology
|July 12, 2024
概括
基因组稳定的结直肠癌 (CRCs),缺乏染色体不稳定性 (CIN) 和微观卫星不稳定性 (MSI),代表了一个不同的亚型. 这些类似GS的CRC具有特定的分子和临床病理特征,包括近位和KRAS/PIK3CA突变.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
背景情况:
- 大肠直肠癌 (CRCs) 通常按染色体不稳定性 (CIN) 或微卫星不稳定性 (MSI) 进行分类.
- 一种基因组稳定的 (GS) CRC亚型已被确定,缺乏CIN和MSI,但其临床病理特征仍未得到充分探索.
研究的目的:
- 定义基因组稳定型 (GS型) CRC亚型的临床病理学和分子特征.
- 将GS类CRC与CIN类CRC的特征进行比较.
主要方法:
- 在437个CRC中使用滴滴数字PCR对8个关键基因的拷贝数变异 (CNV) 的分析.
- 将GS类CRC定义为具有CNV在≤1基因并且没有MSI的CRC.
- 临床病理学和分子特征的比较分析,包括GS类和CIN类CRC之间的突变和基因表达.
主要成果:
- 类似GS的CRC构成了队列中的4.6%.
- 这些瘤倾向于靠近结肠,具有较低的核光学密度和频繁的KRAS和PIK3CA突变.
- 在GS类CRC中观察到异常的KRT7表达.
- 在分子子组之间没有发现显著的生存差异.
结论:
- 类似GS的CRC亚型是一个独特的小亚组,具有特定的临床病理学和分子特征.
- 类似GS的CRC与近位位置,低色核,异常的KRT7表达和频繁的KRAS/PIK3CA突变有关.
- 对这种亚型的进一步研究可能会揭示独特的治疗脆弱性.
相关概念视频
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
02:40Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
02:21Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K